EPHB6 and metastatic malignant neoplasm in the lymph nodes: This study demonstrated that high EphB6 expression was significantly associated with advanced tumor staging and lymph node metastasis, as well as poorer patient outcomes, leading to higher mortality rates (Figure 1).